News Conference News TCT 2012 Registries Demonstrate Positive Long-Term Outcomes with TAVR October 23, 2012
News Conference News TCT 2012 Review of TAVR Use Offers Significant Advances, Positive Outcomes October 22, 2012
News Conference News ESC 2012 ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations Caitlin E. Cox September 04, 2012
News Conference News ESC 2012 French, European Registries Add International Flavor to TAVR Assessment August 29, 2012
News Conference News ESC 2012 TAVR Improves Quality of Life, Reduces Hospitalization in German Registry Yael L. Maxwell August 28, 2012
News Conference News ESC 2012 Dedicated Transapical TAVR Device Shows Promise in Premarket Clinical Research Caitlin E. Cox August 28, 2012
News Conference News ESC 2012 Registries Show Strides for Transcatheter Valve Treatments in Europe Caitlin E. Cox August 27, 2012
News Conference News ESC 2012 Predictors of Aortic Regurgitation After TAVR Delineated August 26, 2012
News Conference News EuroPCR 2012 TAVR Studies Tease Out Influences on Clinical Outcome Caitlin E. Cox May 18, 2012
News Conference News EuroPCR 2012 Mixed Results Shown with Adenosine-Free Pressure Measurement vs. FFR Jason Kahn May 16, 2012
News Conference News EuroPCR 2012 Global Valve-in-Valve Registry: Procedure Technically Challenging, but Highly Feasible Caitlin E. Cox May 16, 2012
News Conference News ACC 2012 Study Looks at Long-term Mortality Predictors in TAVR Patients Jason Kahn March 27, 2012
News Conference News ACC 2012 PARTNER: TAVR Remains as Effective as Surgery at 2 Years March 26, 2012
News Conference News ACC 2012 ADVANCE: TAVR with CoreValve Safe, Effective at 6 Months March 24, 2012
News Conference News Adenosine-Free Pressure Measurement Found Equivalent to FFR L.A. McKeown December 01, 2011
News Conference News ROTAXUS: Rotablation Does Not Improve Stenting Results in Calcified Lesions Yael L. Maxwell November 30, 2011
News Conference News COBRA: Postdilation with Cryoplasty Reduces Restenosis in Diabetic SFA Lesions Jason Kahn November 30, 2011
News Conference News TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year L.A. McKeown November 28, 2011
News Conference News PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis November 27, 2011
News Conference News RIBS III: Alternative DES Best Bet for DES In-Stent Restenosis November 22, 2011